News Search Results
Apr 22, 2024, 17:31 ET Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Harvard Ophthalmology 7.5.2 American Academy of Ophthalmology
More news about: DelveInsight Business Research, LLP
Apr 22, 2024, 17:00 ET SalioGen Therapeutics Announces Data Presentations at 2024 Annual Meetings for the Association for Research in Vision and Ophthalmology (ARVO) and American Society of Gene & Cell Therapy (ASGCT)
four abstracts, including one oral presentation, will be presented at the upcoming annual meetings of the Association for Research in Vision and Ophthalmology (ARVO) and the American Society of Gene & Cell Therapy (ASGCT).
More news about: SalioGen Therapeutics
Apr 22, 2024, 16:35 ET Capsida Biotherapeutics to Present New Data on its Wholly Owned Gene Therapy Programs in Genetic Epilepsy and Parkinson's Disease at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
programs, the Company has validating CNS partnerships with AbbVie, Lilly, CRISPR Therapeutics, and the AbbVie partnership was expanded to include ophthalmology disorders. Capsida was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners and originated from groundbreaking research
More news about: Capsida Biotherapeutics
Apr 22, 2024, 09:00 ET OMNY Health launches new GI real-world data solutions in partnership with leading US gastroenterology practices
gastroenterology providers to our network. Over the past two years, we have made great strides connecting researchers and providers participating in our dermatology and ophthalmology research networks. We look forward to building on that impact in the field of gastroenterology," said Mitesh Rao,
More news about: OMNY Health
Apr 19, 2024, 10:15 ET Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2024
the company will be presenting its latest research results at both the Association for Research in Vision and Ophthalmology annual meeting, and at two meetings sponsored by the Ophthalmology Innovation Source (OIS) in early May. Eric Schlumpf, Stuart Therapeutics' President and CEO, will be presenting
More news about: Stuart Therapeutics
Apr 18, 2024, 06:41 ET Provident Healthcare Partners Advises Community Eye Care Specialists in its Affiliation with EyeSouth Partners
it has advised Community Eye Care Specialists ("CECS") in its affiliation with EyeSouth Partners ("EyeSouth"). CECS is a leading comprehensive ophthalmology provider in the Northern Pennsylvania and Southwestern New York markets focused
More news about: Provident Healthcare Partners LLC
Apr 17, 2024, 09:00 ET SalioGen Therapeutics Announces Selection of Development Candidate for ABCA4-mediated Stargardt Disease
preclinical data supporting SGT-1001 at the May 2024 annual meetings of the Association for Research in Vision and Ophthalmology (ARVO) and the American Society of Gene & Cell Therapy (ASGCT). About Stargardt DiseaseStargardt disease is an inherited
More news about: SalioGen Therapeutics
Apr 15, 2024, 14:00 ET Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024
as "LongBio"), a leading biotech company dedicated to developing innovative protein treatments for nephrology, allergy, respiratory, hematology, ophthalmology, and other autoimmune and rare diseases, proudly announced the release of pre-clinical data of LP-005, a novel bi-functional complement antibody-fusion
More news about: LongBio
Apr 15, 2024, 07:00 ET InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD
Apr 15, 2024, 03:12 ET Optical Biometry Devices Market size is set to grow by USD 93.26 million from 2023-2027, Rise in prevalence of cataracts among geriatric population boost the market, Technavio
Asia, Rest of World (ROW)) Market segmentation by End-user The Optical Biometry Devices Market in the field of ophthalmology is experiencing significant growth, driven by advancements in technology and increasing demand for accurate measurements for cataract surgeries.
More news about: Technavio
Apr 14, 2024, 13:00 ET Mallinckrodt Announces 2024 Extracorporeal Immunomodulation Award
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; and gastrointestinal products. Its Specialty Generics
More news about: Mallinckrodt plc
Apr 10, 2024, 17:24 ET Hospital Furniture Market size is set to grow by USD 7.83 billion from 2023-2027, Rise in international accreditation by hospitals boost the market, Technavio
increasing work-related injuries, age-related diseases, and medical emergencies. The hospital chairs sector includes birthing chairs, dialysis chairs, ophthalmology chairs, ENT chairs, dentistry chairs, pediatric chairs, bariatric chairs, and geriatric chairs. End-users, such as Hospitals, Diagnostic Centers,
More news about: Technavio
Apr 10, 2024, 11:00 ET Applications for the American Board of Medical Specialties 2024-2025 Visiting Scholars Program are Now Available
Boards. The 2024-2025 co-sponsor ABMS Member Boards are: Allergy and Immunology, Dermatology, Emergency Medicine, Obstetrics and Gynecology, Ophthalmology, Otolaryngology–Head and Neck Surgery, Orthopaedic Surgery, Physical Medicine and Rehabilitation, Radiology, Thoracic Surgery, and Urology.
More news about: American Board of Medical Specialties
Apr 09, 2024, 07:00 ET InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD
Apr 07, 2024, 20:00 ET Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that preclinical data on multiple novel bispecific antibodies as well as antibody-drug-conjugates (ADCs) from
More news about: Innovent Biologics
Apr 05, 2024, 08:00 ET Ace Vision Group Names Ken Araki to Its Board of Directors
expertise, that will help guide us forward." Mr. Araki has led global business development at Santen, a pharmaceutical company specializing in ophthalmology, since 2018. He oversees critical business functions, including mergers and acquisitions, product licensing, discovery research collaboration, local
More news about: Ace Vision
Apr 05, 2024, 07:57 ET New VR Solution to Democratize Ophthalmic Surgical Training: Affordable, Portable and Scalable
telemedicine and e-learning platform. "Our partnership with Orbis International not only underscores our commitment to advancing the field of ophthalmology but also highlights the immense potential of VR in creating safer, more effective learning environments for healthcare professionals," said
More news about: Orbis International
Apr 04, 2024, 17:31 ET Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight
Gene Therapies in Ophthalmology Market Report According to DelveInsight's analysis, the market size for gene therapies in ophthalmology reached roughly USD 132 million in 2023 across the 7MM.The ophthalmology segment has emerged
More news about: DelveInsight Business Research, LLP
Apr 04, 2024, 08:10 ET Biomaterials Market size is set to grow by USD 12907.35 mn from 2023-2027, Algenesis Corp., BASF SE & Carpenter Technology Corp., and more to emerge as Some of the Key Vendors, Technavio
biomaterial-based implants, are driving innovation in sectors like orthopedics, cardiovascular, dental, plastic surgery, wound healing, tissue engineering, and ophthalmology. Metallic biomaterials, polymeric biomaterials, ceramic biomaterials, and natural biomaterials are key segments in this market. Metallic biomaterials
More news about: Technavio
Apr 04, 2024, 08:00 ET Professor Marshall Continues to Propel Ace Vision Group Forward
safeguarding public health. He has also held prominent positions at several prestigious institutions and is currently Frost Professor of Ophthalmology at the Institute of Ophthalmology, University College London. "We are honored to add Professor Marshall who is so central in the field of eye lasers," said
More news about: Ace Vision
Apr 04, 2024, 07:00 ET Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
Euan S. Thomson, Ph.D., President of Ophthalmology and Head of the Digital Business Unit for ZEISS Medical Technology. "We've set our sights high to become the top player in the world for ophthalmology by leveraging our workflow solutions, enhancing our portfolio offerings
More news about: Carl Zeiss Meditec AG
Apr 04, 2024, 07:00 ET Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
Euan S. Thomson, Ph.D., President of Ophthalmology and Head of the Digital Business Unit for ZEISS Medical Technology. "We've set our sights high to become the top player in the world for ophthalmology by leveraging our workflow solutions, enhancing our portfolio offerings
More news about: Carl Zeiss Meditec AG
Apr 04, 2024, 06:06 ET Former UnitedHealthcare Vision CEO John Ryan Joins Eyesafe as Senior Advisor
world-class team of eye doctors, engineers, and scientists with decades of experience in electronics, display materials, light management, optometry, and ophthalmology. The Eyesafe brand is trusted by consumers and integrated in millions of digital devices from Dell, HP, Lenovo, LG, ZAGG and more. Eyesafe is recognized
More news about: Eyesafe
Apr 04, 2024, 00:00 ET Cadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of Directors
oversaw development activities and global regulatory approvals for several MS drugs. He served as the head of the Multiple Sclerosis, Neurology, and Ophthalmology Therapeutic Area for Global Development at Sanofi Genzyme, where he oversaw global regulatory approvals of LEMTRADA® (alemtuzumab) and
More news about: Cadenza Bio, Inc.
Apr 03, 2024, 08:00 ET InMode to Present at Upcoming Investor Conferences and Events
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
More news about: InMode LTD